Anondita Medicare Peer Comparison
NSE: ANONDITA
₹1,147.90
As on 07-Sep-2026IST
Market cap
₹2,113 Cr
Revenue (TTM)
₹77 Cr
P/E Ratio
63.2
P/B Ratio
19.5
Div. Yield
0 %
| Anondita Medicare | Gland Pharma | Medplus Health | Laxmi Dental | Onyx Biotec | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
2,113 | 48,948 | 7,929 | 1,088 | 68 |
Revenue (₹ Cr) |
77 | 6,725 | 7,229 | 287 | 62 |
Net Profit (₹ Cr) |
16.42 | 1,128.79 | 210.43 | 28.67 | 4.95 |
Net Margin (%) |
21.28 | 16.02 | 2.88 | 9.68 | 7.85 |
RoE (%) |
43.35 | 11.51 | 11.02 | 9.14 | 12.25 |
Price to Earnings |
63.18 | 43.36 | 37.67 | 35.24 | -- |
Price-To-Book |
19.51 | 4.61 | 3.96 | 4.30 | 1.22 |
Income Statement (₹ Cr)
| Anondita Medicare | Gland Pharma | Medplus Health | Laxmi Dental | Onyx Biotec | |
|---|---|---|---|---|---|
|
Operating Revenue
|
76.99 | 5,616.50 | 6,136.05 | 239.11 | 61.95 |
|
Total Income
|
77.13 | 5,830.11 | 6,184.67 | 242.45 | 63.12 |
|
Total Expenditure
|
51.31 | 4,347.58 | 5,632.59 | 196.46 | 51.58 |
|
EBITDA
|
25.68 | 1,268.92 | 503.47 | 42.65 | 10.37 |
|
Depreciation
|
0.93 | 377.87 | 249.84 | 15.02 | 3.05 |
|
EBIT
|
24.76 | 891.05 | 253.62 | 27.63 | 7.33 |
|
Interest
|
2.94 | 42.00 | 118.95 | 6.17 | 2.02 |
|
Other Income
|
0.14 | 213.61 | 48.62 | 3.34 | 1.17 |
|
Exceptional Items
|
-- | -- | -- | 7.03 | -- |
|
Profit before Tax
|
21.95 | 1,062.66 | 183.29 | 31.83 | 6.48 |
|
Provision for Tax
|
5.54 | 364.13 | 33.06 | 6.45 | 1.52 |
|
Profit after Tax
|
16.42 | 698.53 | 150.23 | 25.38 | 4.95 |
Liabilities (₹ Cr)
| Anondita Medicare | Gland Pharma | Medplus Health | Laxmi Dental | Onyx Biotec | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
37.87 | 9,150.74 | 1,740.56 | 208.54 | 55.62 |
|
Minority Interest
|
1.18 | -- | -0.66 | 0.16 | -- |
|
Non-Current Liabilities
|
12.30 | 457.27 | 991.72 | 12.82 | 9.90 |
|
Current Liabilities
|
26.92 | 1,564.85 | 624.57 | 56.70 | 25.73 |
|
Total Liabilities
|
78.27 | 11,172.85 | 3,456.02 | 284.67 | 91.25 |
Assets (₹ Cr)
| Anondita Medicare | Gland Pharma | Medplus Health | Laxmi Dental | Onyx Biotec | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
23.71 | 4,389.91 | 1,464.69 | 91.16 | 42.06 |
|
Current Assets
|
54.55 | 6,782.94 | 1,891.49 | 187.06 | 49.19 |
|
Total Assets
|
78.27 | 11,172.85 | 3,456.02 | 284.67 | 91.25 |
|
Total Debt*
|
27.39 | 269.21 | 0.00 | 11.37 | 12.46 |
|
Net Current Assets
|
27.64 | 5,218.09 | 1,266.92 | 130.35 | 23.46 |
|
Contingent Liabilities
|
1.58 | 21.38 | 13.78 | -- | -- |
Cashflow (₹ Cr)
| Anondita Medicare | Gland Pharma | Medplus Health | Laxmi Dental | Onyx Biotec | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-10.47 | 914.73 | 540.43 | 43.83 | 1.42 |
|
Cash Flow from Investing Activities
|
-22.91 | 1,704.74 | -317.61 | -29.24 | 0.66 |
|
Cash from Financing Activities
|
33.23 | -433.48 | -227.98 | 110.64 | 5.07 |
|
Net Cash Inflow / Outflow
|
-0.14 | 2,185.99 | -5.16 | 125.23 | 7.15 |
Ratios
Profitability Ratios
| Anondita Medicare | Gland Pharma | Medplus Health | Laxmi Dental | Onyx Biotec | |
|---|---|---|---|---|---|
|
ROCE (%)
|
38.15 | 11.97 | 18.22 | 24.97 | 13.68 |
|
ROE (%)
|
43.35 | 7.82 | 9.21 | 21.40 | 12.25 |
|
ROA (%)
|
20.97 | 6.41 | 4.73 | 12.64 | 5.99 |
|
EBIT Margin (%)
|
33.54 | 26.40 | 9.00 | 19.23 | 18.63 |
|
Net Margin (%)
|
21.28 | 11.98 | 2.43 | 10.47 | 7.85 |
|
Cash Profit Margin (%)
|
22.53 | 19.16 | 6.43 | 16.89 | 12.92 |
Growth Ratios
| Anondita Medicare | Gland Pharma | Medplus Health | Laxmi Dental | Onyx Biotec | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
0.00 | -0.85 | 9.09 | 23.53 | 15.26 |
|
EBIT Growth (%)
|
-- | -1.38 | 34.23 | 76.27 | 35.55 |
|
Net Profit Growth (%)
|
0.00 | -9.57 | 129.09 | 41.44 | 36.31 |
|
EPS Growth (%)
|
0.00 | -9.60 | 129.29 | -35.33 | 0.15 |
|
Book Value Growth (%)
|
0.00 | 4.91 | 10.77 | 569.07 | 119.96 |
Valuation Ratios
| Anondita Medicare | Gland Pharma | Medplus Health | Laxmi Dental | Onyx Biotec | |
|---|---|---|---|---|---|
|
Price / Earnings
|
0.00 | 37.55 | 60.48 | 76.82 | 21.23 |
|
Price / Book Value
|
0.00 | 2.87 | 5.30 | 11.83 | 1.89 |
|
Dividend Yield (%)
|
-- | 1.13 | 0.00 | 0.00 | 0.00 |
|
EV/EBITDA
|
1.56 | 16.15 | 15.80 | 50.94 | 9.45 |
|
Market Cap (₹ Cr)
|
0.00 | 26,233.01 | 9,091.18 | 2,440.49 | 105.17 |
Solvency Ratios
| Anondita Medicare | Gland Pharma | Medplus Health | Laxmi Dental | Onyx Biotec | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.72 | 0.03 | 0.00 | 0.06 | 0.22 |
|
Short term debt to equity ratio
|
0.38 | -- | -- | -- | 0.07 |
|
Current Ratio
|
2.03 | 4.33 | 3.03 | 3.30 | 1.91 |
|
Quick Ratio
|
1.54 | 3.26 | 0.87 | 2.97 | 1.29 |
|
Interest Coverage
|
8.47 | 26.30 | 2.54 | 6.16 | 4.21 |
Operating Efficiency Ratios
| Anondita Medicare | Gland Pharma | Medplus Health | Laxmi Dental | Onyx Biotec | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
34.75 | 27.00 | 0.22 | 15.34 | 32.66 |
|
Asset Turnover
|
0.98 | 0.52 | 1.96 | 1.19 | 0.75 |
|
Receivable days
|
126.83 | 99.92 | 0.90 | 47.00 | 104.89 |
|
Inventory Days
|
63.99 | 108.54 | 78.76 | 33.10 | 74.24 |
|
Payable days
|
39.74 | 138.65 | 21.71 | 152.61 | 142.32 |
|
Cash Conversion Cycle
|
151.09 | 69.81 | 57.95 | -72.51 | 36.81 |